HAMP and postmenopausal osteoporosis: According to Zhang et al. (93), postmenopausal osteoporosis is prevented by hepcidin-induced reductions in iron concentration and PGC-1 expression, which adversely affect osteoclast differentiation, so maybe hepcidin can play a role in treating DOP in the future?